NSE:MAXHEALTH (India)
Â
Ordinary Shares
₹
1,049.3
+12.3 (+1.19%)
Sep 18
Business Description
Max Healthcare Institute Ltd
SIC : 8062
ISIN : INE027H01010
Share Class Description:
NSE:MAXHEALTH: Ordinary SharesTotal Employee Number:
31,127Compare
Compare
Traded in other countries / regions
543220.India Index Membership
NIFTY 50NIFTY 500 IPO Date
2020-08-21Description
Max Healthcare Institute Ltd is one of India's largest private hospital networks, operating a chain of multi-speciality and super-speciality hospitals across North India and other regions. It provides primary, secondary, tertiary and quaternary care through its hospitals and clinics, with core specialities including oncology, cardiology, neurosciences, orthopaedics, transplants and emergency care. The company also offers diagnostic and pathology services and manages certain third-party healthcare facilities under long-term operation and management contracts. Revenue is primarily earned from in-patient and out-patient medical services, surgeries, diagnostics and related healthcare offerings, with most income generated in India. It serves domestic patients as well as international medical travellers. The business operates within a single reportable segment, medical and healthcare services, and has expanded through acquisitions and capacity additions across its hospital network.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.19 | |||||
Equity-to-Asset | 0.62 | |||||
Debt-to-Equity | 0.32 | |||||
Debt-to-EBITDA | 1.43 | |||||
Interest Coverage | 7.34 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 10.56 | |||||
Beneish M-Score | -2.25 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 22.1 | |||||
3-Year EBITDA Growth Rate | 19.3 | |||||
3-Year EPS without NRI Growth Rate | 10.6 | |||||
3-Year FCF Growth Rate | -46.2 | |||||
3-Year Book Growth Rate | 13.1 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 23.06 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 23.12 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 74.35 | |||||
9-Day RSI | 64.47 | |||||
14-Day RSI | 57.65 | |||||
3-1 Month Momentum % | -6.97 | |||||
6-1 Month Momentum % | 3.53 | |||||
12-1 Month Momentum % | -13.55 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.89 | |||||
Quick Ratio | 0.84 | |||||
Cash Ratio | 0.31 | |||||
Days Inventory | 21.93 | |||||
Days Sales Outstanding | 36.24 | |||||
Days Payable | 165.2 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.19 | |||||
Dividend Payout Ratio | 0.13 | |||||
Forward Dividend Yield % | 0.19 | |||||
5-Year Yield-on-Cost % | 0.19 | |||||
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | -0.79 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 78.67 | |||||
Operating Margin % | 21.17 | |||||
Net Margin % | 16.73 | |||||
EBITDA Margin % | 27.97 | |||||
FCF Margin % | 1.09 | |||||
OCF Margin % | 18.13 | |||||
ROE % | 14.49 | |||||
ROA % | 8.97 | |||||
ROIC % | 10.17 | |||||
3-Year ROIIC % | 7.44 | |||||
ROC (Joel Greenblatt) % | 27.78 | |||||
ROCE % | 13.82 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 70.32 | |||||
Forward PE Ratio | 56.03 | |||||
PE Ratio without NRI | 68.46 | |||||
Shiller PE Ratio | 181.8 | |||||
Price-to-Owner-Earnings | 82.27 | |||||
PEG Ratio | 1.67 | |||||
PS Ratio | 11.76 | |||||
PB Ratio | 9.49 | |||||
Price-to-Tangible-Book | 21.54 | |||||
Price-to-Free-Cash-Flow | 689.09 | |||||
Price-to-Operating-Cash-Flow | 62.77 | |||||
EV-to-EBIT | 53.76 | |||||
EV-to-EBITDA | 43.29 | |||||
EV-to-Revenue | 12.11 | |||||
EV-to-FCF | 697.37 | |||||
Price-to-GF-Value | 0.71 | |||||
Price-to-Projected-FCF | 7.85 | |||||
Price-to-Peter-Lynch-Fair-Value | 3.02 | |||||
Price-to-Graham-Number | 8.13 | |||||
Earnings Yield (Greenblatt) % | 1.86 | |||||
FCF Yield % | 0.15 | |||||
Forward Rate of Return (Yacktman) % | 20.35 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Max Healthcare Institute Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 87,120.5 | ||
| EPS (TTM) (₹) | 14.91 | ||
| Beta | 1.1899 | ||
| 3-Year Sharpe Ratio | 0.54 | ||
| 3-Year Sortino Ratio | 1.02 | ||
| Volatility % | 30.88 | ||
| 14-Day RSI | 57.65 | ||
| 14-Day ATR (₹) | 22.399097 | ||
| 20-Day SMA (₹) | 1016.56 | ||
| 12-1 Month Momentum % | -13.55 | ||
| 52-Week Range (₹) | 903 - 1221.9 | ||
| Shares Outstanding (Mil) | 973.31 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Max Healthcare Institute Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Max Healthcare Institute Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2027 | 2027-02-05 11:30 | In 137 days | ||
| Third quarter earnings results for 2027 | 2027-02-05 | In 136 days | ||
| Second quarter earnings conference call for 2027 | 2026-11-17 11:30 | In 57 days | ||
| Second quarter earnings results for 2027 | 2026-11-17 | In 56 days | ||
| First quarter earnings conference call for 2027 | 2026-08-14 11:00 | 1,013.30 (+0.54%) | ||
| First quarter earnings results for 2027 | 2026-08-14 | 1,013.30 (+0.54%) | ||
| General meeting for 2026 | 2026-07-30 10:30 | 1,111.40 (-0.05%) | ||
| Annual report for 2026 | 2026-07-08 | 1,118.40 (-1.28%) | ||
| INR 2.000000 Cash Dividend | 2026-07-03 | 1,127.40 (-1.25%) | ||
| Fourth quarter earnings conference call for 2026 | 2026-05-22 11:00 | 1,091.10 (+0.39%) |
Show
Entries
Max Healthcare Institute Ltd Frequently Asked Questions
What is Max Healthcare Institute Ltd(NSE:MAXHEALTH)'s stock price today?
The current price of NSE:MAXHEALTH is ₹1049.30. The 52 week high of NSE:MAXHEALTH is ₹1221.90 and 52 week low is ₹903.00.
When is next earnings date of Max Healthcare Institute Ltd(NSE:MAXHEALTH)?
The next earnings date of Max Healthcare Institute Ltd(NSE:MAXHEALTH) is 2026-11-17 Est..
Does Max Healthcare Institute Ltd(NSE:MAXHEALTH) pay dividends? If so, how much?
The Dividend Yield %  of Max Healthcare Institute Ltd(NSE:MAXHEALTH) is 0.19% (As of Today), Highest Dividend Payout Ratio of Max Healthcare Institute Ltd(NSE:MAXHEALTH) was 0.13. The lowest was 0.09. And the median was 0.1. The  Forward Dividend Yield % of Max Healthcare Institute Ltd(NSE:MAXHEALTH) is 0.19%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers